RxDoctor Payments Data

Vijaya Gogineni, MD

Pulmonary Disease · Cedar Rapids, IANPI 1821280207

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.0%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 81.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $3,222 and has fallen 99.5% since, to $16 in 2025.

$4,646in general payments, 2019–2025

Across 29 payments — averaging $160.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Pulmonx Corporation$363
  • Covidien LP$293
  • Conmed Corporation$81
  • ERBE USA Inc$69
  • Getinge USA Sales, LLC$24
  • plus $37 from 2 others

What the payments were for

  • Travel & lodging$2,65057%
  • Food & beverage$48010%
  • Education$1,51633%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,646 in reported general payments places this provider in the 65th percentile of 110 pulmonary disease providers in Iowa.

See all pulmonary disease providers in Iowa

Medicare billing

Part B allowed, 2024
$185,592
Medicare patients
629
Services billed
1,823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter326$248,170
Breo ElliptaFluticasone/Vilanterol222$109,383
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr132$61,528
Stiolto RespimatTiotropium Br/Olodaterol Hcl84$46,597
Spiriva HandihalerTiotropium Bromide55$46,041
EliquisApixaban51$38,349
Incruse ElliptaUmeclidinium Bromide86$32,455
Spiriva RespimatTiotropium Bromide45$31,503
Advair HfaFluticasone Propion/Salmeterol49$22,692
SymbicortBudesonide/Formoterol Fumarate47$15,818
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,590
XareltoRivaroxaban16$12,271
Fluticasone-SalmeterolFluticasone Propion/Salmeterol82$10,327
Arnuity ElliptaFluticasone Furoate30$10,171
Albuterol Sulfate HfaAlbuterol Sulfate299$10,067

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →